Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
clonidine (catapres) (1 trial)
Attention Deficit Disorder with Hyperactivity (Phase 4)
Hyperkinesis (Phase 4)
Syndrome (Phase 4)
Tourette Syndrome (Phase 4)
Trials (1 total)
Trial APIs (1 total)